Did you know…
…that 1 in 3 men and 1 in 5 women have an elevated risk for heart attack, and don’t know about it?
The Cardisiography is a convenient and easy screening test for coronary heart disease yielding highly accurate results. The combination of scientific advancement and modern technology has created a new category of screening tests that are fast, smart and easy to apply.
Heart disease can affect seemingly healthy people of all ages! With the Cardisiography, you can diagnose heart hypoperfusions, such as coronary heart disease (CHD), easily, safely and, most importantly, non-invasively. A Cardisiography is suitable for all adults, regardless of age or state of health. Most people affected by heart disease do not show symptoms until they suffer a heart attack, or are only diagnosed after showing strong symptoms. The Cardisiography makes it possible to assess the risk of a heart attack for anyone, giving you an insight into your heart health easily and without great expense!
What makes the Cardisiography different?
The Cardisiography scans the heart in 3D, measuring the heart’s excitation process. Using artificial intelligence, a machine-learning algorithm reliably diagnoses whether a patient is suffering from e.g. a coronary heart disease. The Cardisiography is already patent-pending and is the first non-invasive screening test for the early detection of coronary heart disease.
The measurement technology behind the cardisiography corresponds to the latest and most modern standards. It is a simple measurement in the idle state, the evaluation is carried out by innovative algorithms with the help of AI. Due to the significantly higher sensitivity (> 90%) than with the stress ECG, it is possible for the attending physician to select the right therapy path early. For the first time it is possible to clarify ischemic heart diseases in people at rest with a high degree of accuracy.
Cardisio is the manufacturer of the web service.
The web service is a med. Prod. class 1 according to MDD.Cardisiography is the method used. The data recording device is the data collector that has been placed on the market in accordance with the standards and guidelines listed below. It has been tested against IEC 60601 to ensure the electrical safety of medical products and is therefore a medical grade product.
Applied standards and guidelines:
IEC 60950-1, EN 55032: 2015 Class B, EN55024: 2010 + A1: 2015, 47 CFR Part 15.
More info: product information
Cardisio sensitivity and specificity
The higher the sensitivity of a test, the more safely a potential illness is detected. The Cardisiograph is a high-precision screening test with a sensitivity of 95% at a specificity of 75%. The sensitivity of a diagnostic test procedure indicates the probability of a sick patient actually being identified as sick through the test. The specificity indicates the probability that actual healthy people not suffering from the relevant illness will be identified as healthy. For example, coronary heart disease is only detected in 25% of patients suffering from such using traditional ECG, whereas the Cardisiograph detects disease in 95%!
The Cardisiography is more than just a new screening procedure! The anonymised data is correlated together in the Cardisio HealthNet. This enables Cardisio to provide deductions and information on your health, e.g. whether you fall into a previously unnoticed risk group or your heart health is great in comparison to your age bracket’s average. This information is then all collated into the Cardisiogram, a three-dimensional ECG curve. You can then show this to a trained medical professional to gain a better insight into the kind of heart disease you may be suffering from. This information should not be used as a self-diagnosis or self-treatment. It should not be considered as a replacement for visiting your GP!
Don’t worry, we take protecting your data very seriously and do not pass this on to third parties!
Experience with Cardisio
The Cardisiography identified previously unknown coronary heart disease in seemingly healthy people of all ages. In each case the positive Cardisio test led to further examinations and eventual cardiological treatment that prevented heart attack or other major damage. Below are some real-world examples:
Mai-Lin H., a 53-year-old florist from Hong Kong, visited her general practitioner in January 2019 for her annual checkup. As part of a pilot project, her physician also conducted a Cardisiography test in addition to an ECG.
Heiko, a 16-year-old soccer player in Germany, took a Cardisiography test as part of a medical study that his club participated in. Heiko was physically fit and felt healthy.
Marc G., a 58-year-old from Nairobi in Africa, has been training at a high level for endurance sports for many years. When he suddenly had heart rhythm problems, he was examined by a cardiologist.
Patrick, a 28-year-old bodybuilder from London, lifts weights four to five times a week and even more before competitions. Patrick was examined as a participant in a Cardisio study.
Anneliese B., a 72-year-old retiree from Darmstadt/Germany, was not feeling well on a hot Thursday night in August 2018. She was having difficulty breathing and felt exhausted.
Selina D., a 32-year-old tax accountant from Santo Domingo, Dominican Republic, visited her general practitioner in April 2019 because she did not feel well. She felt weak and had sporadic chest pains.